When utilizing a placebo control condition, researchers must adhere to the ethical principle of informed consent by notifying participants beforehand that they will be assigned to either the genuine treatment or an inactive placebo, even though the exact assignment is concealed until the experiment concludes. Additionally, to ensure ethical fairness, researchers frequently offer the participants who were assigned to the control group the opportunity to receive the actual treatment after the study ends.